Top 2 Drivers for the Global Cryogenic Vaporizer Market | Technavio

Technavio has published a new market research report on the global cryogenic vaporizer market from 2018-2022. (Graphic: Business Wire)

LONDON--()--Technavio market research analysts forecast the global cryogenic vaporizer market to grow at a CAGR of above 6% during the forecast period, according to their latest report.

This market research report segments the global cryogenic vaporizer market into the following four major end-users (chemical and petrochemical, metallurgy, power, and electronics) and three major regions (the Americas, APAC, and EMEA).

Inquire about this report: View market snapshot before purchasing

Register for a My Technavio account and get 10% off your first purchase! View all Technavio’s current offers

In this report, Technavio analysts highlight the top market drivers that are contributing to the growth of the global cryogenic vaporizer market:

  • Increasing popularity of cryogenics in the life sciences industry
  • Natural gas set to surpass coal in primary energy mix in coal-dominant economies

Increasing popularity of cryogenics in the life sciences industry

In areas such as immunotherapy, vaccinations, regenerative medicines, and biopharmaceuticals, the global life sciences industry is constantly experiencing technological advances and innovations. For storage, preservation, and treatment applications, these areas require cryogenic temperatures. For instance, in immunotherapies such as chimeric antigen receptor (CAR) T-cell therapy, immune cells named T-cells are collected from the patient’s blood and are genetically engineered to produce special receptors on the surface known as chimeric antigen receptors. Before being infused into the patient, these CAR-T cells proliferate to billions in number. The T-cells then multiply in the patient’s body and kill the cancer cells with the guidance of an engineered receptor.

Cryogenic systems play a crucial role in storage and activation of CAR-T cells. Biological storage of bone marrow, stem cells, cord blood, human tissues, and other highly sensitive pharmaceutical and biological applications use cryogenic freezers.

According to a senior analyst at Technavio for unit operations, “One of the emerging areas in logistics is cold chain logistics, it has a large demand from end-user segments such as regenerative medicine, stem therapy, immunotherapy, cellular medicine, and CAR-T cell therapy. Many players are offering cold logistics services to various end-users. For example, UPS, which is a healthcare logistics company, provides cryogenic shipping services in Europe.”

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Global cryogenic vaporizer market segmentation

Of the four major end-users, the chemical and petrochemical segment held the largest market share in 2017, accounting for nearly 40%. However, the market share for this application is expected to decrease by 2022.

APAC was the leading region for the global cryogenic vaporizer market in 2017, accounting for a market share of 36%, and the region will continue its dominance through 2022. Both EMEA and the Americas are expected to decline in terms of market share during the forecast period.

Big savings with Technavio this February!

 

Get 20% OFF on all Education Technology reports. This offer is valid only till the 28th of this month.

 

OR

 

Celebrate winter sports with 23% OFF all reports in our Outdoor Gear library (Offer valid from Feb 9-25).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com

Release Summary

Technavio market research analysts forecast the global cryogenic vaporizer market to grow at a CAGR of above 6% during the period 2018-2022.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com